A GLOBAL PERSPECTIVE ON RINGWORM: EPIDEMIOLOGY, BURDEN OF DISEASE, PUBLIC HEALTH IMPLICATIONS AND TREATMENT CHALLENGES - REVIEW ARTICLE
Main Article Content
Keywords
Dermatophytosis, Tinea corporis, Antifungal resistance, Chronic recurrent infections, Public health burden
Abstract
Ringworm (dermatophytosis) has emerged as a significant global public health challenge, particularly in tropical regions like India. The disease manifests primarily as tinea corporis and tinea cruris, affecting skin, nails, and hair. An increasing trend of chronic and recurrent dermatophytosis has been observed, with more frequent reports in dermatology clinics. This has led to heightened interest in the condition at both national and international dermatology conferences. The World Health Organization (WHO) estimates that 20-25% of the global population is affected by superficial fungal infections, with nearly a billion individuals experiencing skin, nail, or hair fungal conditions.
Factors such as poor hygiene, overcrowding, and increased physical activity in hot and humid climates contribute to the high prevalence of ringworm. The rising incidence in children and the higher susceptibility of adults aged 21-50 years are linked to outdoor activities and lifestyle choices, including the use of tight-fitting clothing and synthetic fabrics, which trap moisture and create ideal conditions for fungal growth. Furthermore, the widespread and irrational use of topical steroid-antifungal combinations has worsened the situation, contributing to chronic and treatment-resistant infections.
Despite the escalating number of cases, management guidelines remain outdated. Physicians often rely on hit-and-miss treatment strategies, as current antifungal medications show diminished efficacy. Research on dermatophytosis and its treatment must be reinvigorated, emphasizing molecular mechanisms of antifungal resistance and the role of nonpharmacologic measures in preventing reinfection. The financial burden on families, where multiple members are affected, also calls for a more comprehensive public health approach to tackle this pervasive issue.
References
2. Bhatia VK, Sharma PC. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India. SpringerPlus. 2014 Dec;3(1):134.
3. Bongomin F, Gago S, Oladele R, Denning D. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J Fungi. 2017 Oct 18;3(4):57.
4. Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? Indian Dermatol Online J. 2016;7(2):73.
5. Hasan MA, Fitzgerald SM, Saoudian M, Krishnaswamy G. Dermatology for the practicing allergist: Tinea pedis and its complications. Clin Mol Allergy. 2004;
6. Karanja TW, Osman S, Wainaina M. Analysis and Modelling of Ringworm Infections in an Environment.Global Journal of Pure and Applied Mathematics. ISSN 0973-1768 Volume 15, Number 5 (2019), pp. 649-665 c ©Research India Publications http://www.ripublication.com/gjpam.htm
7. Lee WJ, Kim SL, Jang YH, Lee SJ, Kim DW, Bang YJ, et al. Increasing Prevalence of Trichophyton rubrum Identified through an Analysis of 115,846 Cases over the Last 37 Years. J Korean Med Sci. 2015;30(5):639.
8. Leung AK, Lam JM, Leong KF, Hon KL. Tinea corporis: an updated review. Drugs Context. 2020 Jul 20;9:1–12.
9. Shy R. Tinea Corporis and Tinea Capitis. Pediatr Rev. 2007 May 1;28(5):164–74.
10. Levitt JO, Levitt BH, Akhavan A, Yanofsky H. The Sensitivity and Specificity of Potassium Hydroxide Smear and Fungal Culture Relative to Clinical Assessment in the Evaluation of Tinea Pedis: A Pooled Analysis. Dermatol Res Pract. 2010;2010:1–8.
11. Murgod SM, Shah K. systemic review on efficacy of homoeopathic medicines in tinea infections (Ringworm). Int J Health Sci. 2022 May 4;4631–6.
12. Palathingal Narayanan M, Illathukandy S, Angattukuzhiyil Narayanan V, Kuttiyil A, Surendren R. CLINICAL PROFILE OF DERMATOPHYTOSES IN NORTH KERALA. J Evol Med Dent Sci. 2017 Feb 13;5(87):6461–5.
13. Penmetcha U, Babu Myneni R, Yarlagadda P, Simgamsetty S. A Study of Prevalence of Dermatophytosis in and around Guntur District, Andhra Pradesh, South India. Int J Curr Microbiol Appl Sci. 2016 Sep 15;5(9):702–17.
14. Pires CAA, Cruz NFSD, Lobato AM, Sousa POD, Carneiro FRO, Mendes AMD. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014 Apr;89(2):259–64.
15. Gupta Y, Tuteja S, PG Coordinator & Associate Professor, Department of Materia Medica, Swasthya Kalyan Homoeopathic Medical College & Research Center, Jaipur, Acharya A, et al. Effectiveness of Homoeopathy in Tinea corporis and Tinea cruris – A Prospective, Longitudinal Observational Study. Int J Adv Ayurveda Yoga Unani Siddha Homeopathy. 2021 Mar 12;10(1):618–27.
16. Sahoo A, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016;7(2):77.
17. Shenoy M, Jayaraman J. Epidemic of difficult-to-treat tinea in India: Current scenario, culprits, and curbing strategies. Arch Med Health Sci. 2019;7(1):112.
18. Tuknayat A, Bhalla M, Kaur A, Garg S. Familial Dermatophytosis in India: A Study of the Possible Contributing Risk Factors. J Clin Aesthetic Dermatol. 2020 Feb;13(2):58–60.
19. Verma S, Madhu R. The Great Indian Epidemic of Superficial Dermatophytosis_ An Appraisal.
20. Woo TE, Somayaji R, Haber RM, Parsons L. Diagnosis and Management of Cutaneous Tinea Infections. Adv Skin Wound Care. 2019 Aug;32(8):350–7.
21. Prevalence of tinea corporis and tinea cruris in Chitradurga rural population. IP Indian J Clin Exp Dermatol. 2020 Dec 28;4(3):221–5.
22. Steroid Creams Can Make Ringworm Worse | Fungal Diseases | CDC [Internet]. 2022 [cited 2023 Aug 22]. Available from: https://www.cdc.gov/fungal/diseases/ringworm/steroids.html